Peru

Publication Title: 
Scientific American
Author(s): 
Pringle, Heather
Publication Title: 
Global Public Health

This study is aimed at examining how subsequent Peruvian governments, since 1990, have addressed reproductive rights, HIV/AIDS prevention and treatment, and sexual diversity rights, as well as the drastic policy shifts and its many contradictions. Abortion and contraception consistently generated the deepest public controversies and debates, which made progress in reproductive rights difficult. HIV/AIDS was often portrayed as having the potential to affect everyone, which allowed advocates and activists to achieve some success in advancing HIV/AIDS-related rights.

Author(s): 
C·ceres, C.
Cueto, M.
Palomino, N.
Publication Title: 
The Journal of Adolescent Health: Official Publication of the Society for Adolescent Medicine

PURPOSE: Adolescents who engage in sex can be affected by a range of negative physical and psychological consequences. We intend to analyze the reasons behind first sex, regret, and the association between reasons and regret. METHODS: A questionnaire was implemented to 8,495 high schools students aged 14-18 years residing in the Philippines, El Salvador, and Peru. Sexually active participants responded whether several circumstances were reasons involved in their first sexual relationship. They also responded whether they regretted having already had sexual relationships.

Author(s): 
Osorio, Alfonso
LÛpez-del Burgo, Cristina
Carlos, Silvia
Ruiz-Canela, Miguel
Delgado, Miguel
de Irala, Jokin
Publication Title: 
AIDS and behavior

Role-based sexual identities structure male same-sex partnerships and influence HIV/STI epidemiology among MSM in Latin America. We explored shifting relationships between sexual roles, identities and practices among MSM in Lima, Peru, and implications for HIV/STI prevention. Patterns of HIV/STI epidemiology reflected differential risks for transmission within role-based partnerships with relatively low prevalences of HIV, syphilis, and HSV-2 but higher prevalences of urethral gonorrhea/chlamydia among activo MSM compared with moderno and pasivo participants.

Author(s): 
Clark, Jesse
Salvatierra, Javier
Segura, Eddy
Salazar, Ximena
Konda, Kelika
Perez-Brumer, Amaya
Hall, Eric
Klausner, Jeffrey
Caceres, Carlos
Coates, Thomas
Publication Title: 
Global Heart

The CRONICAS Centre of Excellence in Chronic Diseases, based at Universidad Peruana Cayetano Heredia, was created in 2009 with support from the U.S. National Heart, Lung, and Blood Institute (NHLBI). The vision of CRONICAS is to build a globally recognized center of excellence conducting quality and innovative research and generating high-impact evidence for health. The center's identity is embedded in its core values: generosity, innovation, integrity, and quality.

Author(s): 
Miranda, J. Jaime
BernabÈ-Ortiz, Antonio
Diez-Canseco, Francisco
M·laga, Germ·n
Cardenas, MarÌa K.
Carrillo-Larco, Rodrigo M.
Pesantes, M. Amalia
Araya, Ricardo
Boggio, Oscar
Checkley, William
GarcÌa, Patricia J.
LeÛn-Velarde, Fabiola
Lescano, Andrés G.
Montori, Victor
Pan, William
Rivera-Chira, Maria
Sacksteder, Katherine
Smeeth, Liam
GarcÌa, HÈctor H.
Gilman, Robert H.
Publication Title: 
AIDS (London, England)

OBJECTIVE: To describe the community popular opinion leader (C-POL) intervention employed in the NIMH Collaborative HIV/STD Prevention Trial, including its theoretical, conceptual, and empirical basis, intervention procedures and methods, core elements, and how its content was culturally tailored to address the needs of varied populations.

Author(s): 
NIMH Collaborative HIV/STD Prevention Trial Group
Publication Title: 
Human Resources for Health

BACKGROUND: Deployment of health workforce in rural areas is critical to reach universal health coverage. Students' perceptions towards practice in rural areas likely influence their later choice of a rural post. We aimed at exploring perceptions of students from health professions about career choice, job expectations, motivations and potential incentives to work in a rural area. METHODS: In-depth interviews and focus groups were conducted among medical, nursing and midwifery students from universities of two Peruvian cities (Ica and Ayacucho).

Author(s): 
Huicho, Luis
Molina, Cristina
Diez-Canseco, Francisco
Lema, Claudia
Miranda, J. Jaime
Huayanay-Espinoza, Carlos A.
Lescano, Andrés G.
Publication Title: 
The American Journal of Tropical Medicine and Hygiene

We assessed whether mutations in the Plasmodium falciparum multidrug-resistance gene 1 (pfmdr1) (C1034S, D1042N, and Y1246D) would predict treatment outcome during a 28-day in vivo treatment trial in the Peruvian Amazon. Mefloquine (MQ) was compared with mefloquine-artesunate (MQ-AS) in a randomized, multi-clinic protocol for the first time in the Americas. Of 115 patients enrolled in the in vivo arm, 97 patients were eligible for molecular analysis.

Author(s): 
Pillai, Dylan R.
Hijar, Gisely
Montoya, Ysabel
Marouiño, Wilmer
Ruebush, Trenton K.
Wongsrichanalai, Chansuda
Kain, Kevin C.
Publication Title: 
The American Journal of Tropical Medicine and Hygiene

In the Amazon Basin of Peru, more than 50% of patients with uncomplicated Plasmodium falciparum malaria fail to respond to treatment with chloroquine or sulfadoxine-pyrimethamine. To assist the National Malaria Control Program in identifying an alternative first-line therapy for this region, we conducted a trial of the safety and efficacy of mefloquine (MQ) compared with mefloquine-artesunate (MQ-AS) combination therapy. Patients with uncomplicated P.

Author(s): 
Marquiño, Wilmer
Huilca, María
Calampa, Carlos
Falconí, Eduardo
Cabezas, César
Naupay, Rubén
Ruebush, Trenton K.
Publication Title: 
The American Journal of Tropical Medicine and Hygiene

To assist the Peruvian Ministry of Health in modifying the malaria treatment policy for their north Pacific coastal region, we conducted an in vivo efficacy trial of sulfadoxine-pyrimethamine (SP) and SP plus artesunate (SP-AS) for the treatment for uncomplicated Plasmodium falciparum infections. A total of 197 patients were randomized to therapy with either SP (25 mg/kg of the sulfadoxine component in a single dose on day 0) or a combination of SP plus AS (4 mg/kg on days 0, 1, and 2) and were followed for 28 days for symptoms and recurrence of parasitemia.

Author(s): 
Marquiño, Wilmer
Ylquimiche, Laura
Hermenegildo, Ygor
Palacios, Ana Maria
Falconí, Eduardo
Cabezas, César
Arróspide, Nancy
Gutierrez, Sonia
Ruebush, Trenton K.

Pages

Subscribe to RSS - Peru